A detailed history of Schonfeld Strategic Advisors LLC transactions in Medicinova Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 41,100 shares of MNOV stock, worth $84,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,100
Previous 41,700 1.44%
Holding current value
$84,254
Previous $60,000 43.33%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.13 - $2.1 $677 - $1,260
-600 Reduced 1.44%
41,100 $86,000
Q2 2024

Aug 14, 2024

SELL
$1.28 - $1.57 $640 - $785
-500 Reduced 1.18%
41,700 $60,000
Q1 2024

May 15, 2024

BUY
$1.28 - $1.65 $768 - $990
600 Added 1.44%
42,200 $61,000
Q4 2023

Feb 14, 2024

SELL
$1.38 - $2.06 $827 - $1,236
-600 Reduced 1.42%
41,600 $62,000
Q3 2023

Nov 14, 2023

SELL
$2.01 - $2.6 $200 - $260
-100 Reduced 0.24%
42,200 $88,000
Q2 2023

Aug 14, 2023

SELL
$2.09 - $2.43 $2,090 - $2,430
-1,000 Reduced 2.31%
42,300 $97,000
Q1 2023

May 15, 2023

SELL
$1.95 - $2.54 $2,340 - $3,048
-1,200 Reduced 2.7%
43,300 $93,000
Q4 2022

Feb 14, 2023

SELL
$1.97 - $2.66 $1,773 - $2,394
-900 Reduced 1.98%
44,500 $91,000
Q3 2022

Nov 14, 2022

BUY
$2.1 - $2.6 $210 - $260
100 Added 0.22%
45,400 $99,000
Q2 2022

Aug 15, 2022

SELL
$2.31 - $3.14 $11,781 - $16,014
-5,100 Reduced 10.12%
45,300 $115,000
Q1 2022

May 16, 2022

BUY
$2.19 - $2.81 $12,702 - $16,298
5,800 Added 13.0%
50,400 $135,000
Q4 2021

Feb 14, 2022

BUY
$2.61 - $4.42 $116,406 - $197,132
44,600 New
44,600 $119,000

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $101M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.